Navigation Links
Gladstone scientist Warner C. Greene receives Washington University School of Medicine Alumni Award
Date:4/25/2012

SAN FRANCISCO, CAApril 25, 2012Warner C. Greene, MD, PhDwho directs virology and immunology research at the Gladstone Instituteshas won the 2012 Alumni Achievement Award from the Washington University School of Medicine in St. Louis (WUSTL).

This prestigious award acknowledges outstanding personal achievement and professional accomplishments, with a particular dedication to the Washington University Medical Center. Dr. Greene trained in the Medical Scientist Training Program at WUSTL, considered to be one of the finest physician-scientist training programs in the United States.

"It is an honor and a pleasure to receive this award," said Dr. Greene, who is also a senior investigator at Gladstone and a professor of medicine at the University of California, San Francisco (UCSF), with which Gladstone is affiliated. "It is indeed very gratifying to be recognized by my alma mater."

Other recipients of this year's Alumni Achievement Award include Keith Bridwell, MD; Gary Rachelefsky, MD and Pejman Salimpour, MD.

Under Dr. Greene's direction, virology and immunology research at Gladstone takes a multidisciplinary approach to fighting HIV/AIDSwhich remains a global scourge, with more than 30 million people worldwide living with HIV. He studies the molecular mechanisms that underlie HIV infection. Recently, Dr. Greene's lab identified human protein fragments in semen that enhance the ability of HIV to infect new cellsa discovery that one day could help stem the global spread of this deadly pathogen.

Earlier this month, Dr. Greene was also honored with the 2012 Distinguished Research Career Award from the Ohio State University Center for Retrovirus Research. This award pays tribute to the career of a scientist working in the field of retrovirology. Dr. Greene was recognized for his substantial body of work on the molecular biology, immunology and pathogenesis of HIV-1 and HTLV-1.

"We are delighted that Dr. Greene is being acknowledged for his work to overcome one of the world's most devastating diseases," said R. Sanders Williams, MD, president of Gladstone. "These honors are highly deserved and speak both to his high accomplishments and his dedication to patients."

A widely recognized expert in virology and immunology, Dr. Greene is a member of the Institute of Medicine of the National Academies and a fellow of the American Academy for the Advancement of Science. He is also the president of the Accordia Global Health Foundation, whose mission is to build alliances to fight infectious disease in Africa.

Dr. Greene also serves as co-director of the UCSF-GIVI Center for AIDS Research and is a member of the executive committees of the AIDS Research Institute and the Biomedical Sciences graduate program at UCSF. He is the author of more than 330 scientific papers and has been recognized as one of the 100 Most Cited Scientists in the world.

Before joining Gladstone in 1991 as the Founding Director of the Gladstone Institute of Virology and Immunology, Dr. Greene served as a Senior Investigator at the National Cancer Institute and a Professor of Medicine and Howard Hughes Investigator at Duke University Medical Center.

Dr. Greene earned a bachelor's degree at Stanford University and an MD/ PhD at the Washington University School of Medicine. He completed his internship and residency training in Medicine at the Massachusetts General Hospital at Harvard.


'/>"/>
Contact: Diane Schrick
diane.schrick@gladstone.ucsf.edu
415-734-2538
Gladstone Institutes
Source:Eurekalert

Related biology news :

1. Gladstone scientist Deepak Srivastava named fellow of the AAAS
2. Gladstone scientist receives American Heart Associations Katz prize for cardiovascular research
3. Gladstone founder receives American Heart Association Distinguished Scientist Award
4. Gladstone scientists identify protein form linked to Huntingtons disease
5. Gladstone scientist finds new target for treating symptoms of Parkinsons disease
6. Gladstone scientists offer new insight into the regulation of stem cells and cancer cells
7. Gladstone to receive $5.6 million in federal funds to seek a cure for AIDS
8. Gladstone scientists identify genes involved in embryonic heart development
9. Gladstone scientists uncover mechanism for the major genetic risk factor of Alzheimers disease
10. Gladstone scientists link hepatitis C virus infection to fat enzyme in liver cells
11. Gladstones Shinya Yamanaka wins Kyoto prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/22/2016)... 22, 2016 According ... Market for Consumer Industry by Type (Image, Motion, ... (Communication & IT, Entertainment, Home Appliances, & ... to 2022", published by MarketsandMarkets, the market ... reach USD 26.76 Billion by 2022, at ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... to bring innovative medical technologies, services and solutions to the healthcare market. The ... implementation of various distribution, manufacturing, sales and marketing strategies that are necessary to ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology: